Acura Pharmaceuticals Total Assets 2010-2021 | ACUR

Acura Pharmaceuticals total assets from 2010 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Acura Pharmaceuticals Annual Total Assets
(Millions of US $)
2021 $1
2020 $2
2019 $3
2018 $2
2017 $5
2016 $8
2015 $17
2014 $16
2013 $29
2012 $29
2011 $37
2010 $25
2009 $32
Acura Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2021-12-31 $1
2021-09-30 $1
2021-06-30 $2
2021-03-31 $2
2020-12-31 $2
2020-09-30 $2
2020-06-30 $3
2020-03-31 $2
2019-12-31 $3
2019-09-30 $2
2019-06-30 $2
2019-03-31 $2
2018-12-31 $2
2018-09-30 $2
2018-06-30 $3
2018-03-31 $3
2017-12-31 $5
2017-09-30 $7
2017-06-30 $6
2017-03-31 $9
2016-12-31 $8
2016-09-30 $8
2016-06-30 $10
2016-03-31 $14
2015-12-31 $17
2015-09-30 $19
2015-06-30 $15
2015-03-31 $18
2014-12-31 $16
2014-09-30 $19
2014-06-30 $22
2014-03-31 $25
2013-12-31 $29
2013-09-30 $22
2013-06-30 $22
2013-03-31 $25
2012-12-31 $29
2012-09-30 $31
2012-06-30 $33
2012-03-31 $35
2011-12-31 $37
2011-09-30 $39
2011-06-30 $41
2011-03-31 $23
2010-12-31 $25
2010-09-30 $27
2010-06-30 $29
2010-03-31 $30
2009-12-31 $32
2009-09-30 $35
2009-06-30 $37
2009-03-31 $42
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.002B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.673B 5.66
Dr Reddy's Laboratories (RDY) India $12.551B 19.84
Aspen Pharmacare (APNHY) South Africa $5.574B 0.00
BridgeBio Pharma (BBIO) United States $5.208B 0.00
Bausch Health Cos (BHC) Canada $2.868B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.042B 14.20
Supernus Pharmaceuticals (SUPN) United States $1.695B 0.00
Taysha Gene Therapies (TSHA) United States $0.481B 0.00
Generation Bio (GBIO) United States $0.211B 0.00
Personalis (PSNL) United States $0.078B 0.00
Assembly Biosciences (ASMB) United States $0.072B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00